Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

Luye Pharma Group today announced that the first subject has been enrolled in a Phase 1 clinical trial in China for its LY03021, which was filed through China's Class 1 pathway for innovative drugs.

The Phase 1 clinical trials program increases patients’ access to novel research by bringing it closer to their homes. Distance should never stand between you and the latest medical breakthroughs. As ...

Context Therapeutics Inc. (NASDAQ: CNTX) is one of the best penny stocks under $1 to buy now. Earlier in June, Context ...

Coralville and North Liberty to split cost for extension project on stretch of road that will eventually connect First Avenue ...

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and ...

Ero Copper Corp. (NYSE:ERO) is one of the cheap Canadian stocks to buy now. On July 10, Ero Copper announced the completion ...

The first phase of New Braunfels High School reconstruction is nearing completion, according to a June 16 New Braunfels ISD ...

The Southwest Pond Regional Recreational Area will offer nature trails, restored natural habitat and possibly an urban ...

Celcuity recently released positive results from its phase 3 VIKTORIA-1 trial, and is raising both debt and shares. Read what ...